Teriflunomide Study in MS Kids Does Not Meet Primary Endpoint. However, It Reduces MRI ActivityNovember 29, 2021--Do We Need Different Ways to Measure Treatment Effectiveness in Children with MS?In a recently published study of 155 children and#Multiple Sclerosis·disorders.solutions·Dec 2, 2021Teriflunomide Study in MS Kids Does Not Meet Primary Endpoint. However, It Reduces MRI Activity